Low enzyme content in the pancreas does not reduce the severity of acute pancreatitis induced by bile-pancreatic duct obstruction

Molecular and Cellular Biochemistry

Volumn 240, Issue 1-2, 2002, Pages 75-81

  De La Mano, Ana ^a   Sevillano, Sara ^a   De Dios, Isabel ^a   Vicente, Secundino ^a   Manso, Manuel Antonio ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Acute pancreatitis; Calcium; CCK receptor antagonist; Pancreatic enzymes; Rat

Indexed keywords

AMYLASE; CALCIUM; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; ENZYME ANTIBODY; FLUORESCEIN; FLUORESCEIN DERIVATIVE; ISOTHIOCYANIC ACID; PANCREAS ENZYME; TRYPSINOGEN; ZYMOGEN GRANULE;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASCITES; BILE DUCT OBSTRUCTION; BIOACCUMULATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOSOL; DISEASE COURSE; DISEASE SEVERITY; DRUG POTENCY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME RELEASE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HEMATOCRIT; MALE; MOLECULAR EVOLUTION; NONHUMAN; PANCREAS DUCT STENOSIS; PANCREAS JUICE; RAT; REVIEW; ACUTE DISEASE; ANIMAL; ARTICLE; BILE DUCT; BLOOD; DISEASE MODEL; ENZYMOLOGY; HOSPITALIZATION; INJURY; METABOLISM; OBSTRUCTIVE JAUNDICE; PANCREAS; PANCREAS DUCT; PANCREATITIS; PATHOLOGY; PATHOPHYSIOLOGY; TIME; ULTRASTRUCTURE; WISTAR RAT;

ANIMALIA;

ACUTE DISEASE; AMYLASES; ANIMALS; BILE DUCTS; CALCIUM; CHOLESTASIS, EXTRAHEPATIC; DEVAZEPIDE; DISEASE MODELS, ANIMAL; MALE; MICROSCOPY, ELECTRON; PANCREAS; PANCREATIC DUCTS; PANCREATITIS; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRYPSINOGEN;

EID: 0036855669     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020603724002     Document Type: Review

References (30)

1. Bialek R, Willemer S, Arnold R, Adler G: Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. Scand J Gastroenterol 26: 190-196, 1991
2. Leach SD, Modlin IM, Scheele GA, Gorelick FS: Intracellular activation of digestive enzymes in rat pancreatic acini. Stimulation by high dose of cholecystokinin. J Clin Invest 87: 362-366, 1991
3. Saluja AK, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbaver B, Steer ML: Caerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113: 304-310, 1997
4. Manso MA, Orfao A, Tabernero MD, Vicente V, De Dios I: Changes in both the membrane and the enzyme content of individual zymogen granules are associated with sodium taurocholate-induced pancreatitis in rats. Clin Sci 94: 293-301, 1998
5. García Montero AC, Manso MA, Orfac, A, Vicente S, De Dios I: Zymogen granule alterations in caerulein-induced pancreatitis developed during continuous hydrocortisone administration. Eur J Clin Invest 29: 496-503, 1999
6. Saluja AK, Bhagat L, Lee HS, Bathia M, Frossard JL, Steer ME: Secretagoge-induced digestive enzyme activation and cell injury in rat pancreatic acini. Am J Physiol 39: 6835-6842, 1999
7. Krüger B, Albrecht E, Lerch MM: The role of intracellular calcium signalling in premature protease activation and the onset of pancreatitis. Am J Pathol 157: 43-50, 2000
8. Machado M, Cunha J, Abdo E, Coelho A, Sampetri S, Kubrusli M: Does the pancreatic enzyme content modify the outcome of acute pancreatitis? Pancreas 21: 459, 2000
9. Manso MA, García Montero AC, Tabernero MD, Orfao A, De Dios I: The recovery of acute pancreatifis depends on the enzyme amount stored in zymogen granule at early stages. Mol Cell Biochem 200: 35-41, 1999
10. Uruñuela A, Manso MA, Pinto RM, Orfao A, De Dios I: Enzyme load in pancreatic acinar cells is increased in the early stages of acute pancreatitis induced by duct obstruction in rats. Clin Sci 98: 143-150, 2000
11. Tachibana I, Kataoka K, Imoto M, Umehara K, Sasaki T, Yorizumi H, Kato M, Yamame Y, Kashima K: Effect of a new cholecystokinin antagonist KSG-504 on cerulein-induced acute pancreatitis in rats. Pancreas 8: 521, 1993
12. García Montero AC, Manso MA, Rodríguez AI, De Dios I: Therapeutic and protective effect of subcutaneous injections of L-364, 718 on caerulein-induced pancreatitis. Pancreas 9: 309-315, 1994
13. Pescador R, Manso MA, Rebollo A, De Dios I: Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein. Pancreas 11: 165-172, 1995
14. Czakó L, Takaka T, Varga I, Hai DQ, Tiszlavick L, Hegyi P, Mandi Y, Matkovics B. Lanovics J: The pathogenesis of L-arginine-induced acute pancreatitis: Inflammatory mediators and endogenous cholecystokinin. J Physiol 94: 43-50, 2000
15. Ohshio G, Saluja A, Leli U, Sengupta A, Steer ME: Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice. Pancreas 4: 739-743, 1989
16. Louie DS, Liang JP, Owyang C: Characterization of a new CCK antagonist, L-364,718, in vitro and in vivo studies. Am J Physiol 255: G261-G266, 1988
17. Rodríguez AI, Manso MA, García Montero, AC, Orfao A, De Dios I: Long-term blockade of cholecystokinin (CCK): Effects of L-364, 718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion. Pancreas 15: 314-322, 1997
18. De Dios I, Rodríguez AI, García-Montero AC, Orfao A, Manso MA: Enzyme changes in zymogen CCK and in pancreatic secretion throughout long-term CCK treatment. Peptides 18: 101-110, 1997
19. Hickson JCD: The secretion of pancreatic juice in response to stimulation of the vagus nerves in the pig. J Physiol 206: 275-297, 1970
20. Vanderberghe PA, Ceuppens JL: Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T-lymphocytes with fluo-3, a fluorescent calcium indicator. J Immunol Meth 127: 197-205, 1990
21. De Dios I, Manso MA: Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats. Pancreas 9: 212-218, 1994
22. Zucker KA, Adrian TE, Bilchik AJ, Modlin IM: Effect of the CCK receptor antagonist L-364,718 on pancreatic growth in adult and developing animals. Am J Physiol 257: G511-G516, 1989
23. Ohshio G, Saluja A, Steer ML: Effects of short-term pancreatic duct obstruction in rats. Gastroenterology 100: 196-202, 1991
24. Uruñuela A, Manso MA, de la Mano A, Sevillano S, Orfao A, De Dios I: Asynchronous impairment of calcium homeostasis in different acinar cells after pancreatic duct obstruction in rat. Clin Sci 102: 615-622, 2002
25. Grady T, Mah'Moud M, Otani T, Rhee S, Lerch MM, Gorelick S: Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury. Am J Physiol 275: G1010-G1017, 1998
26. Lüthen R, Owen RL,, Sarbia N, Grendell JH, Niederau C: Premature trypsinogen activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells. Pancreas 17: 38-43, 1998
27. Otsuki M: Pathophysiological role of cholecystokinin in humans. J Gastroenterol Hepatol 15 (suppl): D71-D83, 2000
28. Niederau C, Borchard F, Lüthen R, Niederau M: Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade. Hepato-Gastroenterol 43: 1442-1453, 1996
29. Scheele G, Adler G, Kern H: Exocytosis occurs at the lateral plasma membrane ofthe pancreatic acinar cell during supramaximal secretagogue stimulation. Gastroenterology 92: 345-353, 1987
30. Ward JB, Sutton R, Jenkins SA, Petersen OH: Progressive disruption of acinar cell calcium signaling is a early feature of cerulein-induced pancreatitis in mice. Gastroenterology 111: 481-491, 1996